Faralimomab Reference: HY-P99611 Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb.
Etaracizumab Reference: HY-P99291 Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
Anti-Mouse H-2K Antibody Reference: HY-P99135 Anti-Mouse H-2K Antibody is an anti-mouse H-2K IgG2b antibody inhibitor derived from host mouse.
Vixarelimab Reference: HY-P99519 Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash.
Ocaratuzumab Reference: HY-P99308 Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).
Ravagalimab Reference: HY-P99821 Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease.